OPT 2.78% 35.0¢ opthea limited

Here is the meat of the release"Melbourne, Australia and...

  1. 981 Posts.
    lightbulb Created with Sketch. 207
    Here is the meat of the release

    "
    Melbourne, Australia and Princeton, NJ, June 3, 2024 -- O
    pthea Limited (ASX/NASDAQ:
    OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing
    novel therapies to treat highly prevalent and progressive retinal diseases, including wet
    age-related macular degeneration (wet AMD), today announced that the Company will
    make several presentations at the Clinical Trials at the Summit (CTS)
    Meeting being held
    in Park City, Utah on June 8, 2024. Frederic Guerard, PharmD, Chief Executive Officer
    of Opthea, will participate in a panel, there will be two scientific presentations related to
    the sozinibercept (OPT-302) clinical trial program and a sponsor talk.

    CTS brings together experts from around the world to discuss ongoing clinical trials and
    the latest data with the goal of accelerating advances in vitreoretinal care.

    Opthea Presentations (in program order):

    Session: Clinical Trials Addressing Neovascular AMD (nAMD)
    Scientific Presentation: Implications for Targeting VEGF-C/D: Potential for Vision Gain
    Beyond VEGF-A Inhibition
    Time: 1:02 - 1:06 pm MDT
    Presenter: Megan Baldwin, PhD, MAICD, Founder, Chief Innovation Officer and Executive Director, Opthea

    Scientific Presentation: Superior Functional Outcomes Beyond Standard of
    Care: Update on Sozinibercept Clinical Trials
    Time: 1:06 - 1:10 pm MDT
    Presenter: Julie Clark, MD, Senior Vice President of Clinical Development, Opthea
    Sponsor Talk: Opthea Overview
    Time: 1:39 – 1:49 pm MDT
    Panel: Challenges of Bringing New Treatment Options to Market
    Time: 3:40 - 4:00 pm MDT
    Panelist: Frederic Guerard, PharmD, Chief Executive Officer, Opthea


    "

    Anyone got any experience with the type of new info discussed and to why it is price sensistive ? My question is, given that the topline results won't be released until at least this time in 2025, could this presentation include interim results, safety updates, or early efficacy signals that provide any clues on June 8 (9th Australian time) ?

    Last edited by FreeFromStyle: 03/06/24
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.010(2.78%)
Mkt cap ! $382.0M
Open High Low Value Volume
35.5¢ 36.5¢ 35.0¢ $934.4K 2.624M

Buyers (Bids)

No. Vol. Price($)
10 230715 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 17816 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.